
LGVN
USDLongeveron Inc. Class A Common Stock
$0.800-0.020 (-2.439%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$0.820
Haut
$0.820
Bas
$0.800
Volume
0.38M
Fondamentaux de l'Entreprise
Capitalisation Boursière
16.8M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.95M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Bas $0.633Actuel $0.800Haut $2.31
Actualités Connexes
GlobeNewswire
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
Voir plus
GlobeNewswire
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.